Looking at big Pharma pipelines19 Mar 2021 12:11
The big companies being Gilead, Glaxosmithkline, AbbVie, Johnson and Johnson, Merck, Bristol Myers and Roche. I suspect Glaxosmithkline and Bristol Myers may take an interest in the Synairgen findings. The company that needs to make new acquisitions is Gilead but it might not be in lung anti-virals.